These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23395821)

  • 21. TIMP independence of matrix metalloproteinase (MMP)-2 activation by membrane type 2 (MT2)-MMP is determined by contributions of both the MT2-MMP catalytic and hemopexin C domains.
    Morrison CJ; Overall CM
    J Biol Chem; 2006 Sep; 281(36):26528-39. PubMed ID: 16825197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel processing of beta-amyloid precursor protein catalyzed by membrane type 1 matrix metalloproteinase releases a fragment lacking the inhibitor domain against gelatinase A.
    Higashi S; Miyazaki K
    Biochemistry; 2003 Jun; 42(21):6514-26. PubMed ID: 12767235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7.
    Wang LL; Zhang B; Zheng MH; Xie YZ; Wang CJ; Jin JY
    Curr Top Med Chem; 2020; 20(27):2459-2471. PubMed ID: 32703131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y; Yeon J; Kim HJ; Lee ST
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein engineering of the tissue inhibitor of metalloproteinase 1 (TIMP-1) inhibitory domain. In search of selective matrix metalloproteinase inhibitors.
    Wei S; Chen Y; Chung L; Nagase H; Brew K
    J Biol Chem; 2003 Mar; 278(11):9831-4. PubMed ID: 12515831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation.
    Zhao H; Bernardo MM; Osenkowski P; Sohail A; Pei D; Nagase H; Kashiwagi M; Soloway PD; DeClerck YA; Fridman R
    J Biol Chem; 2004 Mar; 279(10):8592-601. PubMed ID: 14681236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases.
    Miyamori H; Takino T; Kobayashi Y; Tokai H; Itoh Y; Seiki M; Sato H
    J Biol Chem; 2001 Jul; 276(30):28204-11. PubMed ID: 11382769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational insights into the selectivity mechanism of APP-IP over matrix metalloproteinases.
    Geng L; Gao J; Cui W; Tang Y; Ji M; Chen B
    J Comput Aided Mol Des; 2012 Dec; 26(12):1327-42. PubMed ID: 23224743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limited processing of pro-matrix metalloprotease-2 (gelatinase A) overexpressed by transfection in PC-3 human prostate tumor cells: association with restricted cell surface localization of membrane-type matrix metalloproteinase-1.
    Wilson MJ; Jiang A; Wiehr C; Wang X; Sinha AA; Pei D
    J Androl; 2004; 25(2):274-85. PubMed ID: 14760014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinase expression and function during fin regeneration in zebrafish: analysis of MT1-MMP, MMP2 and TIMP2.
    Bai S; Thummel R; Godwin AR; Nagase H; Itoh Y; Li L; Evans R; McDermott J; Seiki M; Sarras MP
    Matrix Biol; 2005 Jun; 24(4):247-60. PubMed ID: 15935631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.
    Kim IS; Yang WS; Kim CH
    Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling.
    Fisher KE; Pop A; Koh W; Anthis NJ; Saunders WB; Davis GE
    Mol Cancer; 2006 Dec; 5():69. PubMed ID: 17156449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of MMP-9 by membrane type-1 MMP/MMP-2 axis stimulates tumor metastasis.
    Li Z; Takino T; Endo Y; Sato H
    Cancer Sci; 2017 Mar; 108(3):347-353. PubMed ID: 27987367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membrane type 1 matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines.
    Maquoi E; Frankenne F; Baramova E; Munaut C; Sounni NE; Remacle A; Noël A; Murphy G; Foidart JM
    J Biol Chem; 2000 Apr; 275(15):11368-78. PubMed ID: 10753951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.
    Will H; Atkinson SJ; Butler GS; Smith B; Murphy G
    J Biol Chem; 1996 Jul; 271(29):17119-23. PubMed ID: 8663332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface.
    Itoh Y; Ito A; Iwata K; Tanzawa K; Mori Y; Nagase H
    J Biol Chem; 1998 Sep; 273(38):24360-7. PubMed ID: 9733724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective function-blocking monoclonal human antibody highlights the important role of membrane type-1 matrix metalloproteinase (MT1-MMP) in metastasis.
    Remacle AG; Cieplak P; Nam DH; Shiryaev SA; Ge X; Strongin AY
    Oncotarget; 2017 Jan; 8(2):2781-2799. PubMed ID: 27835863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of matrix metalloproteinase inhibitors by chemical arrays.
    Kawatani M; Fukushima Y; Kondoh Y; Honda K; Sekine T; Yamaguchi Y; Taniguchi N; Osada H
    Biosci Biotechnol Biochem; 2015; 79(10):1597-602. PubMed ID: 25988721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.